Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Alcon stock logo
ALC
Alcon
$62.50
-2.2%
$77.45
$62.40
$96.88
$31.60B0.931.90 million shs4.54 million shs
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$221.17
-0.6%
$237.59
$146.12
$251.71
$535.63B0.277.86 million shs5.46 million shs
STAAR Surgical Company stock logo
STAA
STAAR Surgical
$26.69
-2.2%
$21.56
$15.59
$30.81
$1.36B1.2934,745 shs445,981 shs
Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Alcon stock logo
ALC
Alcon
0.00%-14.67%-17.34%-19.01%-33.55%
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
0.00%-3.38%-7.73%-7.46%+41.43%
STAAR Surgical Company stock logo
STAA
STAAR Surgical
0.00%+3.49%+30.65%+55.18%+40.33%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Alcon stock logo
ALC
Alcon
$62.50
-2.2%
$77.45
$62.40
$96.88
$31.60B0.931.90 million shs4.54 million shs
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$221.17
-0.6%
$237.59
$146.12
$251.71
$535.63B0.277.86 million shs5.46 million shs
STAAR Surgical Company stock logo
STAA
STAAR Surgical
$26.69
-2.2%
$21.56
$15.59
$30.81
$1.36B1.2934,745 shs445,981 shs
Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Alcon stock logo
ALC
Alcon
0.00%-14.67%-17.34%-19.01%-33.55%
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
0.00%-3.38%-7.73%-7.46%+41.43%
STAAR Surgical Company stock logo
STAA
STAAR Surgical
0.00%+3.49%+30.65%+55.18%+40.33%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Alcon stock logo
ALC
Alcon
2.70
Moderate Buy$85.1236.19% Upside
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
2.67
Moderate Buy$252.4814.15% Upside
STAAR Surgical Company stock logo
STAA
STAAR Surgical
2.00
Hold$19.93-25.33% Downside

Current Analyst Ratings Breakdown

Latest STAA, ALC, and JNJ Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/8/2026
Alcon stock logo
ALC
Alcon
Lower Price TargetEqual Weight$90.00 ➝ $78.00
5/7/2026
Alcon stock logo
ALC
Alcon
Lower Price TargetOverweight$97.00 ➝ $86.00
5/7/2026
Alcon stock logo
ALC
Alcon
Lower Price TargetOutperform$95.00 ➝ $85.00
5/7/2026
Alcon stock logo
ALC
Alcon
Lower Price TargetOutperform$98.00 ➝ $90.00
5/6/2026
Alcon stock logo
ALC
Alcon
Set Price Target$70.00
5/6/2026
Alcon stock logo
ALC
Alcon
Lower Price TargetBuy$87.00 ➝ $82.00
5/6/2026
Alcon stock logo
ALC
Alcon
Reiterated RatingBuy$100.00
4/24/2026
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
DowngradeBuy (B+)Buy (B)
4/22/2026
STAAR Surgical Company stock logo
STAA
STAAR Surgical
DowngradeSell (D-)Sell (E+)
4/20/2026
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
Boost Price TargetBuy$244.00 ➝ $266.00
4/16/2026
Alcon stock logo
ALC
Alcon
UpgradeStrong-Buy
(Data available from 5/9/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Alcon stock logo
ALC
Alcon
$10.40B2.97$5.37 per share11.65$44.75 per share1.40
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$94.19B5.65$14.03 per share15.76$33.73 per share6.56
STAAR Surgical Company stock logo
STAA
STAAR Surgical
$239.44M5.55N/AN/A$6.92 per share3.86
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Alcon stock logo
ALC
Alcon
$980M$1.6637.6516.191.687.70%7.11%4.98%N/A
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$26.80B$8.6525.5717.582.1821.83%32.60%13.29%7/15/2026 (Estimated)
STAAR Surgical Company stock logo
STAA
STAAR Surgical
-$80.45M-$1.63N/A121.32N/A-33.60%-10.03%-7.70%5/13/2026 (Confirmed)

Latest STAA, ALC, and JNJ Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/13/2026Q1 2026
STAAR Surgical Company stock logo
STAA
STAAR Surgical
$0.13N/AN/AN/A$78.72 millionN/A
5/5/2026Q1 2026
Alcon stock logo
ALC
Alcon
$0.80$0.85+$0.05$0.39$2.64 billion$2.71 billion
4/14/2026Q1 2026
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$2.68$2.70+$0.02$2.14$23.60 billion$24.06 billion
3/3/2026Q4 2025
STAAR Surgical Company stock logo
STAA
STAAR Surgical
$0.14-$0.37-$0.51-$0.37$75.54 million$57.80 million
2/24/2026Q4 2025
Alcon stock logo
ALC
Alcon
$0.79$0.78-$0.01$0.44$2.71 billion$2.72 billion
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Alcon stock logo
ALC
Alcon
N/AN/AN/AN/A4 Years
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$5.202.35%+5.25%60.12%64 Years
STAAR Surgical Company stock logo
STAA
STAAR Surgical
N/AN/AN/AN/AN/A

Latest STAA, ALC, and JNJ Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
4/14/2026
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
quarterly$1.342.23%5/26/20265/26/20266/9/2026
4/2/2026
Alcon stock logo
ALC
Alcon
annual$0.280.43%5/6/20265/6/20265/7/2026
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Alcon stock logo
ALC
Alcon
0.19
2.20
1.33
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
0.46
1.03
0.77
STAAR Surgical Company stock logo
STAA
STAAR Surgical
N/A
4.55
3.74

Institutional Ownership

CompanyInstitutional Ownership
Alcon stock logo
ALC
Alcon
53.86%
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
69.55%
STAAR Surgical Company stock logo
STAA
STAAR Surgical
96.70%

Insider Ownership

CompanyInsider Ownership
Alcon stock logo
ALC
Alcon
1.52%
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
0.16%
STAAR Surgical Company stock logo
STAA
STAAR Surgical
0.59%
CompanyEmployeesShares OutstandingFree FloatOptionable
Alcon stock logo
ALC
Alcon
25,942494.62 million487.10 millionOptionable
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
138,2002.41 billion2.40 billionOptionable
STAAR Surgical Company stock logo
STAA
STAAR Surgical
1,21149.79 million49.49 millionOptionable

Recent News About These Companies

2 Small-Cap Stocks Worth Your Attention and 1 We Avoid
Staar Surgical (STAA) Gets a Hold from Wedbush
Stock Movers: Intel, Meta, Staar Surgical

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Alcon stock logo

Alcon NYSE:ALC

$62.50 -1.38 (-2.15%)
Closing price 05/8/2026 03:59 PM Eastern
Extended Trading
$63.03 +0.53 (+0.84%)
As of 05/8/2026 07:05 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Alcon Inc. researches, develops, manufactures, distributes, and sells eye care products for eye care professionals and their patients worldwide. The company's Surgical segment offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgical solutions, incisional instruments, surgical custom packs, and other products for surgical procedures. Its cataract products include Centurion vision system, LenSx laser system, ARGOS biometer, LuxOR surgical ophthalmic microscope, SMARTCATARACT health platform, NGENUITY 3D visualization system, Verion reference unit and Verion digital marker, and ORA system for intra-operative measurements; custom pak surgical procedure packs; vitreoretinal products comprising constellation vision systems, procedure packs, lasers and hand-held microsurgical instruments, and grieshaber and MIVS instruments, as well as scissors, forceps and micro-instruments, medical grade vitreous tamponades, and Hypervit vitrectomy probes; refractive surgery products, including WaveLight lasers and Contoura Vision used for LASIK treatment; EX-PRESS glaucoma filtration device; and implantable products, including AcrySof IQ products, such as monofocal IOLs and advanced technology IOLs for the correction of presbyopia and astigmatism at the time of cataract surgery. Its Vision Care segment provides daily disposable, reusable, and color-enhancing contact lenses; ocular health products, such as dry eye, glaucoma, contact lens care, and ocular allergies; and ocular vitamins and redness relievers. The company was formerly known as Alcon Universal S.A. and changed its name to Alcon Inc. in December 2001. Alcon Inc. was founded in 1945 and is headquartered in Geneva, Switzerland.

Johnson & Johnson stock logo

Johnson & Johnson NYSE:JNJ

$221.17 -1.34 (-0.60%)
Closing price 05/8/2026 03:59 PM Eastern
Extended Trading
$221.25 +0.08 (+0.04%)
As of 05/8/2026 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The MedTech segment includes a portfolio of products used in the interventional solutions, orthopaedics, surgery, and vision categories. The company was founded by Robert Wood Johnson I, James Wood Johnson, and Edward Mead Johnson Sr. in 1887 and is headquartered in New Brunswick, NJ.

STAAR Surgical stock logo

STAAR Surgical NASDAQ:STAA

$26.69 -0.59 (-2.16%)
Closing price 05/8/2026 04:00 PM Eastern
Extended Trading
$26.88 +0.18 (+0.69%)
As of 05/8/2026 05:31 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia. It markets its products to health care providers, including ophthalmic surgeons, vision and surgical centers, hospitals, government facilities, and distributors, as well as products are primarily used by ophthalmologists. The company sells its products directly through its sales representatives in the United States, Japan, Germany, Spain, Canada, the United Kingdom, and Singapore, as well as through own representatives and independent distributors in China, Korea, India, France, Benelux, Italy, and internationally. STAAR Surgical Company was incorporated in 1982 and is headquartered in Lake Forest, California.